Vergleich

Parkin ELISA Kits (PARK2; human, mouse, rat, canine) 96T

Hersteller Fivephoton
Kategorie
Typ Elisa-Kit
Specific against Human, Mouse, Rat, Canine
Menge 96T
ArtNr Prk-ELISA
Targets AURKB;;PRKN
eClass 6.1 32160605
eClass 9.0 32160605
Lieferbar
Poisonous Material
Sodium Azide (0.1%)
Highlights
Fully pre-configured sandwich ELISA format providing convenience, and optimal selectivity and sensitivity.
Affinity purified polyclonal capture antibody coated on plate. Separate HRP-conjugated detection antibody.
Colorimetric detection at 450 nM
Rapid assay format. Total incubation time at 37C is 1 hr.
Background
The included ELISA 96-well micro-strip plate is provided pre-coated with an affinity purified rabbit polyclonal antibody selective to the antigen. Upon addition of samples to the wells, the antigen in solution binds to the antibody and becomes indirectly linked to the solid support. After washes of unbound materials, a second affinity purified polyclonal antibody conjugated with horse-radish peroxidase (HRP) is added, followed by a second incubation period. Unbound antibody is washed, and then color reagents are added, which upon conversion by HRP, become blue colored. A stop solution is added to block further reaction between HRP and the colorimetric substrates, converting the solution into a yellow coloration. An absorbance multiplate reader is used to quantitate the colorimetric reaction at 450 nm. This assay requires approximately 1.5 hrs to complete at 37C.
References
Xabier Agirre, et.al. (2006). Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International journal of cancer Journal international du cancer 118 (8) p. 1945-1953.

Nonmotor Symptoms in Patients with PARK2 MutationsAsako Yoritaka, Yumi Shimo, Yasushi Shimo, Yuichi Inoue, Hiroyo Yoshino, Nobutaka Hattori (2011). Parkinsons disease 2011 p. 47364.

George Poulogiannis, Rebecca E McIntyre, Maria Dimitriadi, John R Apps, Catherine H Wilson, Koichi Ichimura, Feijun Luo, Lewis C Cantley, Andrew H Wyllie, David J Adams, Mark J Arends (2010). PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Proceedings of the National Academy of Sciences of the United States of America 107 (34) p. 15145-15150.

Yasuhiro Yamamura (2007). The long journey to the discovery of PARK2. Rinsho shinkeigaku Clinical neurology 47 (11) p. 749-751.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 96T
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 06.06.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen